Возбудитель

Apple scab

Spilocaea pomi

Description

Spilocaea pomi represents the anamorph state of the fungal pathogen responsible for apple scab, which is considered the most devastating disease affecting apple trees globally. Belonging to the division Ascomycota, this fungus targets leaves, buds, blossoms, and fruits, causing significant cosmetic and physiological damage to the host.

The primary host for this pathogen is the domestic apple (Malus domestica). Symptoms include the appearance of olive-green to black velvety spots on leaf surfaces and fruit skins. Severe infections cause early leaf drop, fruit cracking, and the development of distorted, corky tissues, significantly reducing market value and storage life.

The life cycle of the pathogen is complex, involving both sexual and asexual stages. Overwintering occurs primarily within infected leaf litter on the orchard floor. During spring rainfall, ascospores are discharged and dispersed via wind and water splashes to primary infection sites on new foliage, initiating the disease cycle.

Environmental conditions are the main drivers of infection. Spilocaea pomi thrives in cool, wet weather, requiring persistent leaf wetness and moderate temperatures to germinate and infect host tissues. Orchards with poor airflow and high humidity are at a much higher risk of epidemic outbreaks during the early growing season.

Effective management requires a multi-faceted approach. Cultural practices, such as removing fallen leaves to eliminate overwintering sites, are essential. Furthermore, chemical control programs involve the strategic application of protective and curative fungicides, timed precisely to coincide with infection periods and the phenological stages of apple tree development.

  • Pruning trees to ensure optimal light and air circulation.
  • Raking and destroying infected leaf litter in autumn.
  • Monitoring weather conditions to predict infection risks.
  • Implementing a systematic fungicide application program.
Content graph

Вызывает болезни · 1

Community

Discussion

No discussions yet — be the first.